Furst, D. E., McSweeney, P. A., Crofford, L. J., McDonagh, K. T., Sullivan, K. M., Mayes, M. D., … Nash, R. A. (2004). High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs. In ARTHRITIS AND RHEUMATISM (Vol. 50, pp. S693–S693). San Antonio, TX: WILEY-LISS.

Furst, D. E., P. A. McSweeney, L. J. Crofford, K. T. McDonagh, K. M. Sullivan, M. D. Mayes, J. L. Nelson, et al. “High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs.” In ARTHRITIS AND RHEUMATISM, 50:S693–S693. WILEY-LISS, 2004.

Furst DE, McSweeney PA, Crofford LJ, McDonagh KT, Sullivan KM, Mayes MD, et al. High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs. In: ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2004. p. S693–S693.

Furst, D. E., et al. “High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs.” ARTHRITIS AND RHEUMATISM, vol. 50, no. 9, WILEY-LISS, 2004, pp. S693–S693.

Furst DE, McSweeney PA, Crofford LJ, McDonagh KT, Sullivan KM, Mayes MD, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Lee J, Henstorf G, Abidi M, Nash RA. High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2004. p. S693–S693.